ASKA Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch ASKA Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis (NCT03931915) | ASKA Pharmaceutical Co., Ltd. | 2019-05-08 |
Track ASKA Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.